4.4902.16% ( +0.095 )
Delay Closed: Nov 16, 16:08:11Overview
CHINARES PHARMA (3320)
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other he...
- Open
- 4.450
- High
- 4.490
- Low
- 4.365
- Prev. Close
- 4.395
- Volume
- 4.46M
- Turnover
- 19.89M
- Avg Price
- 4.460
- Bid/Ask Ratio
- -89.74%
- Amplitude
- 2.84%
- 52wk High
- 6.290
- Volume Ratio
- 0.47
- Turnover Ratio
- 0.07%
- 52wk Low
- 4.100
- HK Mkt Cap
- 28.21B
- Market CapHKD
- 28.21B
- P/ETTM
- 5.90
- P/EDynamic
- 5.60
- P/EStatic
- --
- EPSTTM
- 0.761
- EPSDynamic
- 0.801
- EPSStatic
- --
- BVPS
- 9.68
- P/B
- 0.46
- HK Shares
- 6.28B
- Dividend YieldTTM
- 5.34%
- DividendTTM
- 0.2396
- Shares
- 6.28B
- Min lot size
- 500
- Currency
- HKD
CHINARES PHARMA Analyst Rating
View moreForecast & Rating
Sep 9, 2026Price forecast
HK$6.4944.52%
Forecast & RatingBuy
11analysts
- Strong buy54.55%
- Buy36.36%
- Hold9.09%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 6
- Buy
- 4
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
News
PUBT · China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond Issuance
Weekly Review · Weekly Recap | CHINARES PHARMA -5.79%, consensus target above spot
PUBT · China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Commercial’s Nine-Month Net Profit Rises to RMB 1.75 Billion
PUBT · China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Holdings’ Nine-Month Net Profit Falls to RMB 6.97 Billion
Tip Ranks · China Resources Pharma Discloses Nine-Month Unaudited Results of Dong-E-E-Jiao
Tip Ranks · China Resources Pharmaceutical Subsidiary Tasly Posts Higher Profit on Lower Revenue
